The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia

被引:47
作者
Hankins, Jane S. [1 ]
Fortner, Gail L. [1 ]
McCarville, M. Beth [2 ]
Smeltzer, Matthew P. [3 ]
Wang, Winfred C. [1 ]
Li, Chin-Shang [4 ]
Ware, Russell E. [1 ]
机构
[1] St Jude Childrens Hosp, Ctr Comprehens Sickle Cell, Dept Hematol, Memphis, TN 38105 USA
[2] St Jude Childrens Hosp, Ctr Comprehens Sickle Cell, Dept Radiol Sci, Memphis, TN 38105 USA
[3] St Jude Childrens Hosp, Ctr Comprehens Sickle Cell, Dept Biostat, Memphis, TN 38105 USA
[4] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA
关键词
transcranial Doppler; stroke; sickle cell disease;
D O I
10.1111/j.1365-2141.2008.07167.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) [time-averaged mean velocity (TAMV) 170-199 cm/s] have increased risk of primary stroke, but receive no specific therapy. Some will convert to abnormal velocities (TAMV >= 200 cm/s) with further increase in stroke risk. In 2003, our centre initiated universal TCD screening, targeting all children (aged 2-16 years) with SCA. TCD examinations were repeated at intervals based on initial results. To determine rates and risk factors for TCD conversion, we reviewed all examinations since 2003, excluding patients receiving hydroxycarbamide (hydroxyurea) or transfusions. Of the eligible population, 274 children (98%) were screened at a median age of 7.1 years (range 1.7-18.2). Fifty-four patients (20%) had conditional TAMV either on initial screening or a subsequent examination. The 18-month cumulative incidence of conversion from conditional to abnormal TAMV was 23%. Age, initial TAMV, laboratory values, blood pressure and oxygen saturation were not significantly associated with conversion. Our cohort provides systematic longitudinal evaluation of an unselected paediatric population universally screened and retested at regular intervals. Our data document a high conversion rate to abnormal velocities among untreated children with SCA. Therapy should be considered for the prevention of conversion to abnormal TCD velocities.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 15 条
[1]   THE USE OF TRANSCRANIAL ULTRASONOGRAPHY TO PREDICT STROKE IN SICKLE-CELL DISEASE [J].
ADAMS, R ;
MCKIE, V ;
NICHOLS, F ;
CARL, E ;
ZHANG, DL ;
MCKIE, K ;
FIGUEROA, R ;
LITAKER, M ;
THOMPSON, W ;
HESS, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :605-610
[2]  
Adams RJ, 2005, NEW ENGL J MED, V353, P2769
[3]   TCD in sickle cell disease: an important and useful test [J].
Adams, RJ .
PEDIATRIC RADIOLOGY, 2005, 35 (03) :229-234
[4]   Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler [J].
Adams, RJ ;
McKie, VC ;
Carl, EM ;
Nichols, FT ;
Perry, R ;
Brock, K ;
McKie, K ;
Figueroa, R ;
Litaker, M ;
Weiner, S ;
Brambilla, D .
ANNALS OF NEUROLOGY, 1997, 42 (05) :699-704
[5]   Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study [J].
Adams, RJ ;
Brambilla, DJ ;
Granger, S ;
Gallagher, D ;
Vichinsky, E ;
Abboud, MR ;
Pegelow, CH ;
Woods, G ;
Rohde, EM ;
Nichols, FT ;
Jones, A ;
Luden, JP ;
Bowman, L ;
Hagner, S ;
Morales, KH ;
Roach, ES .
BLOOD, 2004, 103 (10) :3689-3694
[6]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[7]   Stroke prevention trial in sickle cell anemia [J].
Adams, RJ ;
McKie, VC ;
Brambilla, D ;
Carl, E ;
Gallagher, D ;
Nichols, FT ;
Roach, S ;
Abboud, M ;
Berman, B ;
Driscoll, C ;
Files, B ;
Hsu, L ;
Hurlet, A ;
Miller, S ;
Olivieri, N ;
Pegelow, C ;
Scher, C ;
Vichinsky, E ;
Wang, W ;
Woods, G ;
Kutlar, A ;
Wright, E ;
Hagner, S ;
Tighe, F ;
Lewin, J ;
Cure, J ;
Zimmerman, RA ;
Waclawiw, MA .
CONTROLLED CLINICAL TRIALS, 1998, 19 (01) :110-129
[8]   Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease [J].
Brambilla, Donald J. ;
Miller, Scott T. ;
Adams, Robert J. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (03) :318-322
[9]   Declining stroke rates in Californian children with sickle cell disease [J].
Fullerton, HJ ;
Adams, RJ ;
Zhao, SJ ;
Johnston, SC .
BLOOD, 2004, 104 (02) :336-339
[10]   Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience [J].
Gulbis, B ;
Haberman, D ;
Dufour, D ;
Christophe, C ;
Vermylen, C ;
Kagambega, F ;
Corazza, F ;
Devalck, C ;
Dresse, MF ;
Hunninck, K ;
Klein, A ;
Le, PQ ;
Loop, M ;
Maes, P ;
Philippet, P ;
Sariban, E ;
Van Geet, C ;
Ferster, A .
BLOOD, 2005, 105 (07) :2685-2690